BioWorld MedTech

Feb. 25, 2011

Deals roundup: Thermo Fisher in plan to sell diagnostic labs for $940M

Thermo Fisher Scientific (Waltham, Massachusetts) reported that it has signed definitive agreements to sell Athena Diagnostics (Worcester, Massachusetts) to Quest Diagnostics (Madison, New Jersey) for $740 million. (Medical Device Daily) Read More

Cook launches EchoTip ProCore, new histology needle for EUS

International report: Mazor's PIPE dreams up $6.3M in new capital funds for company

RFID Hospial Smart Room uses real-time patient data

Agreements/contracts: Masimo to license Pulse for Royal Fornia monitors

MDD's food for med-tech thought

New ventures: Biolase Technology forms new imaging business unit

Clarification

Product Briefs

HIT roundup: Lumedx launches Enabling EHR suite for meaningful use

People in the News

MDD's Diagnostic Extra

Today's news in brief

BioWorld

BioWorld briefs for Dec. 27, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for December 27, 2024.

Illustration of neurons with Lewy bodies

Enhanced Cognition: Lewy body dementia phase II pumps stock

BioWorld

Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...

Experimental mRNA gene therapy suppresses preeclampsia in mice

BioWorld MedTech

A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...

Lab glassware and antibodies art concept

Probing bidirectional cancer-autoimmune link can yield new targets

BioWorld Science

Cancer and autoimmunity are “often thought of as being at opposite ends of the immune response,” Ana Anderson told her audience at a joint meeting of the NIH’s...